Follicular lymphomas (FL) are closely associated with a t(14;18)(q32;q21) translocation, leading to a bcl2 protein overproduction. This translocation probably constitutes a very early step in the development of the disease. Besides the cytogenetic assay, t(14;18) detection can be achieved using either Southern blot or polymerase chain reaction (PCR). Since 1990, several publications have reported discrepancies between the results of cytogenetic and molecular analysis of t(14;18). Using methods able to explore long DNA fragments, several authors reported breakpoints located outside the usual breakpoint regions. However, these techniques cannot be easily used in routine. The aim of this study was to develop a simple PCR assay to amplify rearrangements usually not detected in FL. We selected a group of 83 patients with a t(14;18) on cytogenetic analysis: using usual probes and primers, 54/83 (65.1%) showed a MBR rearrangement, 7/83 (8.4%) were mcr positive and 22/83 (26.5%) remained negative. Among these 22 rearrangements, nine could be detected using this new PCR assay. Four breakpoints were located in a 20 bp area suggesting a recurrent breakpoint cluster close to an Alu repetitive sequence. Finally, remaining negative cases (13/83, 15.6%) suggest that other breakpoints are located between the MBR and mcr regions. Leukemia (2000) 14, 1563-1569.
Introduction
The t(14;18)(q32;q21) is the most frequent cytogenetic abnormality observed in follicular lymphoma (FL), 1 but also in part of large cell lymphomas. This translocation joins the BCL2 gene located on chromosome 18q21 with the immunoglobulin heavy chain locus on chromosome 14q32. [2] [3] [4] This rearrangement leads to an overproduction of bcl2 protein, known to be a potent apoptosis inhibitor. 5, 6 This mechanism probably represents a very early step of the malignant process. 7 Because of an inhibited apoptosis, additional genomic lesion may occur and probably lead to progressive disease. 8, 9 The BCL2-JH rearrangement represents a highly specific molecular marker of FL which can be useful not only for diagnosis but also for the monitoring of minimal residual disease (MRD). 10, 11 Detection of the translocation can be achieved using either conventional cytogenetics or Southern blotting or a polymerase chain reaction (PCR) assay using specific probes or primers. Most BCL2 breakpoints (60%) are located in the middle of the untranslated part of the third exon, in a 150 bp region named major breakpoint region (MBR). 12 Others breaks 13 are located in a less clustered 500 bp region, 20 kb downstream from the gene, called minor breakpoint cluster region (mcr) (Figure 1 ). Rare breakpoints (variant cluster region, vcr) can occur in the 5Ј part of the gene and are involved in variant translocations with light chain immunoglobulin genes. 14 Since the development of molecular studies using Southern blot or PCR with conventional primers or probes, several publications reported differences in the incidence of the BCL2-JH rearrangement in follicular lymphoma when comparing cytogenetics and molecular detection. [15] [16] [17] In 1991, Zelenetz et al 18 reported an enhanced detection of the t(14;18) translocation using pulse-field gel electrophoresis (PFGE), exploring longer DNA fragments. They could explain the detection failure of conventional molecular methods by the location of some breakpoints 'outside the range of conventional probes and primers'. More recently, Akasaka et al 19 and Willis et al, 20 using different 'long PCR' techniques, detected some BCL2-JH rearrangements 3Ј from the third BCL2 exon, between the MBR and mcr regions. These techniques, however, cannot be easily included in routine laboratory assays. The aim of this work was to define simple PCR conditions for an enhanced detection of these breakpoints.
Materials and methods

Patients
For this retrospective study, 83 patients were retained on the following criteria: FL according to the REAL classification 21 ( Table 1 ), 14;18 translocation upon conventional cytogenetic analysis, search for a molecular rearrangement using both Southern blotting and PCR analysis. The rearranged DNA from an additional patient (case 357), in which cytogenetic analysis failed, was also cloned and sequenced, and used to generate a 3Ј BCL2 genomic probe.
Cytogenetic analysis
Methods for cytogenetic analysis have been previously described. 22 Karyotypes are described according to the International System for Human Cytogenetic Nomenclature. 23 
Southern blot analysis
DNA blotting was performed as previously described. 24 Ten micrograms of high molecular weight DNA extracted from 19 close to an Alu repetitive sequence (a), and ( ) Willis et al. 20 p1027 is a genomic probe designed to explore 3Ј MBR rearrangements. 
Conventional PCR analysis
BCL2 primers (GensetOligos; Genset, Paris, France) were chosen to be complementary of the recurrent breakpoints: MBR (5Ј-TAT GGT GGT TTG ACC TTT AG-3Ј) 11 and mcr ('MC8' 5Ј-GAC TCC TTT ACG TGC TGG TAC C-3Ј) as previously described, 27 in combination with a JH consensus primer (5Ј-ACC TGA GGA GAC GGT GAC CAG GGT-3Ј).
11
PCR were performed in an automated thermal cycler (GeneAmp PCR System 4800; Perkin-Elmer, Foster City, CA, USA). Each reaction mixture (50 l) 28 contained 1 g genomic DNA, 5 l 10 × buffer (Perkin-Elmer), 8 l of dNTPs mixture (1.25 mM), 50 pmol of each primer and 1 U of Taq polymerase (AmpliTaq; Perkin-Elmer). The PCR protocol was: denaturation at 94°C for 5 min followed by 35 cycles comprising denaturation at 94°C for 45 s, primer annealing at 55°C for 1 min and DNA extension at 72°C for 1 min 30 s, further extension at 72°C for 10 min and rapid cooling to 10°C. PCR products (20 l) were analyzed by 1.5% agarose gel electrophoresis (SeaKem GTG agarose; FMC Bioproducts, Rockland, ME, USA) and visualized under UV illumination after ethidium bromide staining. PCR products were then transferred to positively charged nylon membranes (Hybond N+; Amersham Pharmacia Biotech, Buckingham, UK) for specific hybridization with biotinylated oligonucleotide probes (GensetOligos; Genset): 5Ј-TTA GAG AGT TGC TTT ACG TG-3Ј for the MBR and MC12 5Ј-GAT GGC TTT GCT GAC AGG TAT-3Ј for the mcr. Revelation was achieved by an enzymatic chemi-luminescent reaction (Enzyme-Conjugate HRP-SA/Perkin Elmer N808-0091 and revelation kit ECL Amersham RPN 2105) and autoradiography. A negative control containing all PCR reagents and water was included in all experiments.
3Ј MBR PCR assay
Primer oligo 48: 5Ј-CTC CAG TTG GCC ACC ATT AGC T-3Ј was chosen to explore the 3Ј region of the BCL2 gene in combination with the previously described JH primer. 11 The PCR reaction mix consisted of 1 g DNA, 5 l 10 × buffer (Amersham Pharmacia Biotech), 200 mol/l of each dNTP, 50 pmol of each primer and 2.5 U Taq DNA polymerase (Amersham Pharmacia Biotech) in a total volume of 50 l. To enhance the detection rate for long targets, we used an increasing elongation time. Amplification protocol was: denaturation at 93°C for 2 min; 10 cycles of denaturation at 93°C for 10 s, primer annealing at 60°C for 30 s and DNA extension at 68°C for 2 min, followed by 20 cycles: denaturation at 93°C Leukemia for 10 s, primer annealing at 60°C for 30 s and DNA extension at 68°C for 2 min + (20 s x n), further extension at 68°C for 7 min and rapid cooling to 10°C. PCR products were then analyzed as described above. Specificity of PCR products was checked using a 3Ј BCL2 biotinylated probe 5Ј-GCT ATA ATG GCA CTT TGC-3Ј, located at the 3Ј end of the third BCL2 exon.
Cloning PCR products
All PCR products were purified by gel extraction (QIAquick Gel Extraction Kit, Quiagen, Hilden, Germany) and controlled for both specificity (hybridization with 3Ј BCL2 biotinylated probe) and concentration. At least 5 l of PCR products were ligated into a plasmid vector (pGEMT Easy; Promega, Madison, WI,USA). Electrocompetent DH5␣ cells were transformed using an EasyjectT Prima electroporator (EquiBio, Kent, UK) set at 2.5 kV, 25 F and 201⍀. Bacteria were plated on X-Gal/IPTG/Ampicillin plates, and white colonies were picked and grown overnight at 37°C. Plasmid DNA was extracted using Quiaprep 8 (Quiagen), digested, run on 1% agarose and blotted on nylon N+ membrane (Hybond; Amersham) for a specificity control before larger amplification (Maxi prep; Quiagen).
Sequence analysis
Cloned PCR products were sequenced using the ThermoSequenase Kit (Amersham Pharmacia Biotech) according to the supplier's instructions, and specific primers (data not shown). Sequences were compared with the GenBank databases using Advanced BLAST 2.0 and FASTA programs (www.ncbi.nlm.nih.gov/BLAST).
3Ј MBR probe
A genomic probe, p1027, was isolated from the cloned rearrangement of another patient (Table 1, Figure 1 ). Amplification of genomic DNA was performed using oligo 48 as forward primer and a reverse internal primer 5Ј-GAA GAG GGA CAC ACT CCT CCC TCT-3Ј chosen to amplify a near 1 kb product. Purification, ligation and cloning, as well as probe labelling were performed as described above.
Results
Conventional molecular analysis
Among the 83 patients retained, usual probes and primers allowed the detection of a BCL2-JH rearrangement in 61/83 (73.5%) (Southern blot, PCR or both). A MBR breakpoint was found in 54/83 (65.1%) and a mcr break in 7/83 (8.4%). In 20/83 (24.1%) cases, PCR analysis alone was positive and Southern blotting in 3/83 (3.6%). Both molecular techniques failed to detect a BCL2-JH rearrangement in 22/83 (26.5%) cases.
Southern blot analysis of negative PCR cases
In four cases, a careful examination of Southern blots found a heavily rearranged band (Ͼ20 kb) on the sole BamHI digest. In these cases, a co-migration of pFL3 and JH signals was observed (Table 1) . According to the BCL2 gene restriction map, these results suggested a breakpoint location 3Ј from the third exon.
3Ј PCR assay
From the 22 cases that were negative upon conventional analysis, nine rearrangements could be amplified (9/83, 10.8%) (Figure 2 ). The size of PCR products range from 0.8 to 3 kb (Table 1 ). All amplified rearrangements were cloned and sequenced, as well as the whole 3 kb region (GenBank AF217803) (Figure 3 ).
Breakpoint location on chromosome 18
Using several sequence primers (Figure 1) , we determined the breakpoint location in all nine cases. Four breaks were clus- tered near the first 5Ј intronic EcoRI restriction site, in a 20 bp area, while the other five breaks were spread in a 2 kb area. The most distal breakpoint was located 2.7 kb from the 3Ј end of the third exon. For all PCR products, the immunoglobulin part was reduced and most breaks involved the JH6 or JH4 segments (Table 1) .
Leukemia
Improving 3Ј BCL2 restriction analysis
Using p1027 and a HindIII digestion, we could detect one or more rearranged band ranging from 1.5 to 5 kb in five patients (Table 1 ). This genomic probe seems to be useful to improve Leukemia BCL2-JH rearrangement detection using Southern analysis with usual restriction enzyme.
Discussion
The identification of cytogenetic abnormalities in neoplastic disorders proved to be useful for the understanding of the oncogenic mechanisms leading to cell transformation, and to characterize genetic markers of the diseases. The presence of such markers can help the physician in diagnosis and in the follow up of patients after chemotherapy.
Follicular lymphoma is closely associated with a t(14;18)(q32;q21) and the molecular assessment of the resulting BCL2-JH rearrangement using PCR techniques is nowadays performed routinely. However, despite numerous probes and primers exploring recurrent breakpoints in the BCL2 gene, several publications focused on the lack of molecular techniques able to characterize the rearrangement in a number of t(14;18)-positive cases.
In 1991, using a PFGE technique, Zelenetz et al 18 reported that the analysis of long DNA fragments allowed the detection of molecular rearrangements in some previously negative cases. A few years later, the development of long DNA fragment amplification 29 allowed a similar approach for PCR techniques. Willis et al 20 and Akasaka et al 19 using different long range amplification methods (LDI-PCR, LA-PCR) could detect some BCL2-JH rearrangements 3Ј from the third BCL2 exon, between the MBR and mcr regions. Although efficient in amplifying long fragments of genomic DNA, these PCR techniques are too complex for routine laboratory use.
In the treatment of malignant lymphoma, the development of intensive chemotherapy associated with autologous stem cell transplantation requires efficient techniques allowing clonality assessment, patient follow-up and MRD evaluation. This can be achieved using at least two kinds of genetic markers: disease-specific markers, such as the BCL2-JH rearrangement, or lineage-specific markers such as immunoglobulin gene rearrangements in B cells. 30, 31 These latter markers do not require long-range PCR techniques but may be exposed to false negative results due to ongoing mutations observed in FL cells 32 or to the difficulties encountered in amplifying a residual clone-specific signal in a polyclonal background. Moreover, in a recent publication, Von Neuhoff et al 33 reported a lower specificity of CDR-PCR vs BCL2-JH PCR in detecting relapse or evolution of the disease after autologous transplantation in a FL series.
The aim of this work was to develop specific and simple assays to detect BCL2-JH rearrangements in most FL patients bearing a 14;18 translocation.
The analysis of our series of patients shows that rearrangements can be detected by molecular technique using previously reported probes and primers in 73.5% cases, 65% (54/83) at the MBR and 8.4% (7/83) at the mcr, but also reveals that these tools are unable to detect a rearrangement in 26.5% (22/83). These results are similar to previously reported ones, 16, 17 and confirm the importance of the discrepancy separating cytogenetic and molecular results.
A careful analysis of Southern blots obtained from PCRnegative patients allowed recognition of a heavy (Ͼ20 kb) BamHI rearranged band in four patients ( Table 1 ), indicating that the corresponding breaks were probably located 3Ј from the third BCL2 exon, in agreement with the data reported by Akasaka et al 19 and Willis et al. 20 We developed a simple PCR assay using a primer located in the 3Ј part of the third BCL2 exon together with a usual JH consensus primer, and conventional PCR conditions except for an increasing extension time. Under these conditions, the translocation of nine of the 22 negative samples could be amplified and cloned in plasmid vectors. The size of the amplified fragments varied from 0.8 to 3 kb. All nine translocation breakpoints were sequenced, as well as the whole 3 kb region. The location of breakpoints is indicated on the 3Ј BCL2 restriction map (Figure 1) . Four breaks were located in a 20 bp area, close to an Alu repetitive sequence and 110 bp 5Ј from the first EcoRI site downstream of the third BCL2 exon. Interestingly, two of the three breaks reported by Akasaka et al 19 are located in the same narrow region. Taken together, these six breakpoints represent a real new breakpoint cluster. The involvement of Alu sequences in the illegitimate recombination process has been previously postulated. 19 The other five breakpoints are spread on the whole 3 kb region, as were the other two breaks reported by Willis and Akasaka.
Recently, Ló pez-Guillermo et al 34 reported a correlation between the BCL2 rearrangement pattern and clinical outcome in a large cohort of patients with indolent FL. Whereas previous studies (cytogenetic or molecular data), found a better overall survival in MBR rearranged patients, these authors found that the better course was associated with the presence of an mcr rearrangement and the worse with the absence of any BCL2 rearrangement using usual MBR and mcr primers. In such series, it would be interesting to evaluate the frequency and outcome of patients bearing 3Ј BCL2 rearrangements.
Despite this additional PCR assay, we failed to amplify the rearrangement of some patients (13/83, 15.6%) with a 14;18 translocation. As previously reported, other breakpoints are involved and other assays using more 3Ј primers should be tested to reach an exhaustive exploration of BCL2 gene rearrangements in FL.
Finally, we developed a genomic probe to characterize BCL2 rearrangements occurring in the 3Ј part of the gene, which can be included in Southern blot analysis of FL.
In conclusion, this new PCR assay has proved to be useful and efficient in detecting breaks located 1 to 3 kb downstream from the third BCL2 exon and to increase the PCR detection rate of BCL2-JH rearrangements in patients with a 14;18 translocation. The frequency and prognostic value of these breakpoints have to be further evaluated in large series of patients. However, remaining negative cases indicate that other potential breakpoints are still to be identified between the MBR and mcr regions.
